Marco Moreira

2.4k total citations
10 papers, 208 citations indexed

About

Marco Moreira is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Marco Moreira has authored 10 papers receiving a total of 208 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 5 papers in Oncology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Marco Moreira's work include Renal cell carcinoma treatment (4 papers), Renal and related cancers (3 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Marco Moreira is often cited by papers focused on Renal cell carcinoma treatment (4 papers), Renal and related cancers (3 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Marco Moreira collaborates with scholars based in France, United States and Taiwan. Marco Moreira's co-authors include Yann Vano, Nicolas Epaillard, Stéphane Oudard, Audrey Simonaggio, Cheng‐Ming Sun, Catherine Sautès‐Fridman, Wolf H. Fridman, Florent Petitprez, Maxime Meylan and Johanna Verneau and has published in prestigious journals such as Journal of Clinical Oncology, Nature reviews. Immunology and European Journal of Cancer.

In The Last Decade

Marco Moreira

10 papers receiving 208 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Marco Moreira France	7	132	105	96	50	31	10	208
Mei Xie China	11	100 0.8×	99 0.9×	93 1.0×	41 0.8×	65 2.1×	28	251
Mathieu Larroquette France	6	131 1.0×	90 0.9×	95 1.0×	95 1.9×	45 1.5×	12	239
Maxime Brunet France	5	136 1.0×	47 0.4×	70 0.7×	113 2.3×	29 0.9×	11	226
Takuma Onoe Japan	8	141 1.1×	83 0.8×	59 0.6×	22 0.4×	23 0.7×	19	236
Robert A. Belderbos Netherlands	7	136 1.0×	156 1.5×	39 0.4×	68 1.4×	52 1.7×	14	283
Jens‐Carsten Rückert Germany	6	90 0.7×	101 1.0×	99 1.0×	35 0.7×	63 2.0×	19	255
Nesteene J. Param United States	6	71 0.5×	82 0.8×	55 0.6×	73 1.5×	37 1.2×	12	214
Patricia Rich United States	7	103 0.8×	39 0.4×	54 0.6×	27 0.5×	24 0.8×	19	159
María José Paúles Spain	6	134 1.0×	34 0.3×	53 0.6×	29 0.6×	39 1.3×	14	198

Countries citing papers authored by Marco Moreira

Since Specialization

Citations

This map shows the geographic impact of Marco Moreira's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marco Moreira with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marco Moreira more than expected).

Fields of papers citing papers by Marco Moreira

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marco Moreira. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marco Moreira. The network helps show where Marco Moreira may publish in the future.

Co-authorship network of co-authors of Marco Moreira

This figure shows the co-authorship network connecting the top 25 collaborators of Marco Moreira. A scholar is included among the top collaborators of Marco Moreira based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marco Moreira. Marco Moreira is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Moreira, Marco, et al.. (2024). Induced pluripotent stem cell-derived macrophages as a platform for modelling human disease. Nature reviews. Immunology. 25(2). 108–124. 8 indexed citations

Dunsmore, Garett, Mathilde Bied, Marco Moreira, et al.. (2023). Multicellular tumor spheroid model to study the multifaceted role of tumor-associated macrophages in PDAC. Drug Delivery and Translational Research. 14(8). 2085–2099. 6 indexed citations

Gantzer, Justine, Guillaume Davidson, Noëlle Weingertner, et al.. (2022). Immune-Desert Tumor Microenvironment in Thoracic SMARCA4-Deficient Undifferentiated Tumors with Limited Efficacy of Immune Checkpoint Inhibitors. The Oncologist. 27(6). 501–511. 36 indexed citations

Simonaggio, Audrey, et al.. (2021). Tumor Microenvironment Features as Predictive Biomarkers of Response to Immune Checkpoint Inhibitors (ICI) in Metastatic Clear Cell Renal Cell Carcinoma (mccRCC). Cancers. 13(2). 231–231. 45 indexed citations

Epaillard, Nicolas, Audrey Simonaggio, Réza Elaidi, et al.. (2020). BIONIKK: A phase 2 biomarker driven trial with nivolumab and ipilimumab or VEGFR tyrosine kinase inhibitor (TKI) in naïve metastatic kidney cancer. Bulletin du Cancer. 107(5). eS22–eS27. 35 indexed citations

Simonaggio, Audrey, Nicolas Epaillard, Réza Elaidi, et al.. (2020). Impact des signatures moléculaires sur le choix du traitement systémique du cancer du rein métastatique. Bulletin du Cancer. 107(5). S24–S34. 4 indexed citations

Moreira, Marco, et al.. (2020). https://cdrjournal.com/article/view/3531. Cancer Drug Resistance. 3(3). 454–471. 14 indexed citations

Sautès‐Fridman, Catherine, Johanna Verneau, Cheng‐Ming Sun, et al.. (2020). Tertiary Lymphoid Structures and B cells: Clinical impact and therapeutic modulation in cancer. Seminars in Immunology. 48. 101406–101406. 57 indexed citations

Brant, Ayslan Castro, et al.. (2014). 457: Diversity of methylation patterns in HPV16 LCR in cervical cancer. European Journal of Cancer. 50. S110–S111. 1 indexed citations

10.

Ewald, Ingrid Petroni, Fernando Regla Vargas, Marco Moreira, et al.. (2008). Prevalence of BRCA1 and BRCA2 founder mutations in Brazilian hereditary breast and ovarian cancer families. Journal of Clinical Oncology. 26(15_suppl). 22108–22108. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact